Exact Mass: 449.1991
Exact Mass Matches: 449.1991
Found 500 metabolites which its exact mass value is equals to given mass value 449.1991
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Thesinine 4'-O-glucoside
Thesinine 4-O-glucoside is found in tea. Thesinine 4-O-glucoside is an alkaloid from the seeds of Borago officinalis (borago). Alkaloid from the seeds of Borago officinalis (borago). Thesinine 4-O-glucoside is found in tea.
Ethyl n-allyl-n-[(e)-2-methyl-3-[4-(4-amidinophenoxycarbonyl)-phenyl]propenoyl]amino acetate
Iberdomide
N-Ethyl-N-(6,6-dimethyl-2-hepten-4-ynyl)-3-((3,3'-bithiophen-5-yl)methoxy)benzenemethanamine
N-[2,6-Bis(1-methylethyl)phenyl]-N'-[4-[(4-nitrophenyl)thio]phenyl]urea
dihydrogeranylgeranyl-PP
Dihydrogeranylgeranyl-pp is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Dihydrogeranylgeranyl-pp can be found in a number of food items such as chives, nanking cherry, muscadine grape, and towel gourd, which makes dihydrogeranylgeranyl-pp a potential biomarker for the consumption of these food products.
1beta-Benzoyloxy-4-methyl-6,21;14,20-dicyclo-atid-16-en-2alpha,9,15beta-triol|1beta-benzoyloxy-4-methyl-6,21;14,20-dicyclo-atid-16-ene-2alpha,9,15beta-triol
Lys Thr Ser Asp
C27H31NO5_8H-Pyrano[2,3-f]quinolin-8-one, 2,7,9,10-tetrahydro-10-hydroxy-9-methoxy-10-(4-methoxyphenyl)-2-methyl-2-(4-methyl-3-penten-1-yl)-, (2S,9R,10R)
C27H31NO5_8H-Pyrano[2,3-f]quinolin-8-one, 2,7,9,10-tetrahydro-10-hydroxy-9-methoxy-10-(4-methoxyphenyl)-2-methyl-2-(4-methyl-3-penten-1-yl)-, (2S,9R,10R)
Ala Cys Glu Lys
Ala Cys Lys Glu
Ala Cys Arg Thr
Ala Cys Thr Arg
Ala Glu Cys Lys
Ala Glu Lys Cys
Ala Lys Cys Glu
Ala Lys Glu Cys
Ala Met Gln Thr
Ala Met Thr Gln
Ala Gln Met Thr
Ala Gln Thr Met
Ala Arg Cys Thr
Ala Arg Thr Cys
Ala Ser Ser Trp
Ala Ser Trp Ser
Ala Thr Cys Arg
Ala Thr Met Gln
Ala Thr Gln Met
Ala Thr Arg Cys
Ala Trp Ser Ser
Cys Ala Glu Lys
Cys Ala Lys Glu
Cys Ala Arg Thr
Cys Ala Thr Arg
Cys Cys Lys Pro
Cys Cys Pro Lys
Cys Glu Ala Lys
Cys Glu Lys Ala
Cys Ile Asn Thr
Cys Ile Gln Ser
Cys Ile Ser Gln
Cys Ile Thr Asn
Cys Lys Ala Glu
Cys Lys Cys Pro
Cys Lys Glu Ala
Cys Lys Pro Cys
Cys Leu Asn Thr
Cys Leu Gln Ser
Cys Leu Ser Gln
Cys Leu Thr Asn
Cys Asn Ile Thr
Cys Asn Leu Thr
Cys Asn Thr Ile
Cys Asn Thr Leu
Cys Pro Cys Lys
Cys Pro Lys Cys
Cys Gln Ile Ser
Cys Gln Leu Ser
Cys Gln Ser Ile
Cys Gln Ser Leu
Cys Gln Thr Val
Cys Gln Val Thr
Cys Arg Ala Thr
Cys Arg Thr Ala
Cys Ser Ile Gln
Cys Ser Leu Gln
Cys Ser Gln Ile
Cys Ser Gln Leu
Cys Thr Ala Arg
Cys Thr Ile Asn
Cys Thr Leu Asn
Cys Thr Asn Ile
Cys Thr Asn Leu
Cys Thr Gln Val
Cys Thr Arg Ala
Cys Thr Val Gln
Cys Val Gln Thr
Cys Val Thr Gln
Asp Gly Lys Met
Asp Gly Met Lys
Asp Lys Gly Met
Asp Lys Met Gly
Asp Lys Ser Thr
Asp Lys Thr Ser
Asp Met Gly Lys
Asp Met Lys Gly
Asp Ser Lys Thr
Asp Ser Thr Lys
Asp Thr Lys Ser
Asp Thr Ser Lys
Glu Ala Cys Lys
Glu Ala Lys Cys
Glu Cys Ala Lys
Glu Cys Lys Ala
Glu Lys Ala Cys
Glu Lys Cys Ala
Glu Lys Ser Ser
Glu Ser Lys Ser
Glu Ser Ser Lys
Gly Asp Lys Met
Gly Asp Met Lys
Gly Lys Asp Met
Gly Lys Met Asp
Gly Met Asp Lys
Gly Met Lys Asp
Gly Met Arg Ser
Gly Met Ser Arg
Gly Asn Pro Tyr
Gly Asn Tyr Pro
Gly Pro Asn Tyr
Gly Pro Tyr Asn
Gly Arg Met Ser
Gly Arg Ser Met
Gly Ser Met Arg
Gly Ser Arg Met
Gly Ser Thr Trp
Gly Ser Trp Thr
Gly Thr Ser Trp
Gly Thr Trp Ser
Gly Trp Ser Thr
Gly Trp Thr Ser
Gly Tyr Asn Pro
Gly Tyr Pro Asn
Ile Cys Asn Thr
Ile Cys Gln Ser
Ile Cys Ser Gln
Ile Cys Thr Asn
Ile Asn Cys Thr
Ile Asn Thr Cys
Ile Gln Cys Ser
Ile Gln Ser Cys
Ile Ser Cys Gln
Ile Ser Gln Cys
Ile Thr Cys Asn
Ile Thr Asn Cys
Lys Ala Cys Glu
Lys Ala Glu Cys
Lys Cys Ala Glu
Lys Cys Cys Pro
Lys Cys Glu Ala
Lys Cys Pro Cys
Lys Asp Gly Met
Lys Asp Met Gly
Lys Asp Ser Thr
Lys Asp Thr Ser
Lys Glu Ala Cys
Lys Glu Cys Ala
Lys Glu Ser Ser
Lys Gly Asp Met
Lys Gly Met Asp
Lys Met Asp Gly
Lys Met Gly Asp
Lys Pro Cys Cys
Lys Ser Asp Thr
Lys Ser Glu Ser
Lys Ser Ser Glu
Lys Ser Thr Asp
Lys Thr Asp Ser
Leu Cys Asn Thr
Leu Cys Gln Ser
Leu Cys Ser Gln
Leu Cys Thr Asn
Leu Asn Cys Thr
Leu Asn Thr Cys
Leu Gln Cys Ser
Leu Gln Ser Cys
Leu Ser Cys Gln
Leu Ser Gln Cys
Leu Thr Cys Asn
Leu Thr Asn Cys
Met Ala Gln Thr
Met Ala Thr Gln
Met Asp Gly Lys
Met Asp Lys Gly
Met Gly Asp Lys
Met Gly Lys Asp
Met Gly Arg Ser
Met Gly Ser Arg
Met Lys Asp Gly
Met Lys Gly Asp
Met Asn Ser Val
Met Asn Val Ser
Met Gln Ala Thr
Met Gln Thr Ala
Met Arg Gly Ser
Met Arg Ser Gly
Met Ser Gly Arg
Met Ser Asn Val
Met Ser Arg Gly
Met Ser Val Asn
Met Thr Ala Gln
Met Thr Gln Ala
Met Val Asn Ser
Met Val Ser Asn
Asn Cys Ile Thr
Asn Cys Leu Thr
Asn Cys Thr Ile
Asn Cys Thr Leu
Asn Gly Pro Tyr
Asn Gly Tyr Pro
Asn Ile Cys Thr
Asn Ile Thr Cys
Asn Leu Cys Thr
Asn Leu Thr Cys
Asn Met Ser Val
Asn Met Val Ser
Asn Pro Gly Tyr
Asn Pro Tyr Gly
Asn Ser Met Val
Asn Ser Val Met
Asn Thr Cys Ile
Asn Thr Cys Leu
Asn Thr Ile Cys
Asn Thr Leu Cys
Asn Val Met Ser
Asn Val Ser Met
Asn Tyr Gly Pro
Asn Tyr Pro Gly
Pro Cys Cys Lys
Pro Cys Lys Cys
Pro Gly Asn Tyr
Pro Gly Tyr Asn
Pro Lys Cys Cys
Pro Asn Gly Tyr
Pro Asn Tyr Gly
Pro Tyr Gly Asn
Pro Tyr Asn Gly
Gln Ala Met Thr
Gln Ala Thr Met
Gln Cys Ile Ser
Gln Cys Leu Ser
Gln Cys Ser Ile
Gln Cys Ser Leu
Gln Cys Thr Val
Gln Cys Val Thr
Gln Ile Cys Ser
Gln Ile Ser Cys
Gln Leu Cys Ser
Gln Leu Ser Cys
Gln Met Ala Thr
Gln Met Thr Ala
Gln Ser Cys Ile
Gln Ser Cys Leu
Gln Ser Asp Thr
Gln Ser Glu Ser
Gln Ser Ile Cys
Gln Ser Leu Cys
Gln Ser Ser Glu
Gln Ser Thr Asp
Gln Thr Ala Met
Gln Thr Cys Val
Gln Thr Met Ala
Gln Thr Thr Thr
Gln Thr Val Cys
Gln Val Cys Thr
Gln Val Thr Cys
Arg Ala Cys Thr
Arg Ala Thr Cys
Arg Cys Ala Thr
Arg Cys Thr Ala
Arg Gly Met Ser
Arg Gly Ser Met
Arg Met Gly Ser
Arg Met Ser Gly
Arg Ser Gly Met
Arg Ser Met Gly
Arg Thr Ala Cys
Arg Thr Cys Ala
Ser Ala Ser Trp
Ser Ala Trp Ser
Ser Cys Ile Gln
Ser Cys Leu Gln
Ser Cys Gln Ile
Ser Cys Gln Leu
Ser Asp Lys Thr
Ser Asp Thr Lys
Ser Glu Lys Ser
Ser Glu Ser Lys
Ser Gly Met Arg
Ser Gly Arg Met
Ser Gly Thr Trp
Ser Gly Trp Thr
Ser Ile Cys Gln
Ser Ile Gln Cys
Ser Lys Asp Thr
Ser Lys Glu Ser
Ser Lys Ser Glu
Ser Lys Thr Asp
Ser Leu Cys Gln
Ser Leu Gln Cys
Ser Met Gly Arg
Ser Met Asn Val
Ser Met Arg Gly
Ser Met Val Asn
Ser Asn Met Val
Ser Asn Val Met
Ser Gln Cys Ile
Ser Gln Cys Leu
Ser Gln Ile Cys
Ser Gln Leu Cys
Ser Arg Gly Met
Ser Arg Met Gly
Ser Ser Ala Trp
Ser Ser Glu Lys
Ser Ser Lys Glu
Ser Ser Trp Ala
Ser Thr Asp Lys
Ser Thr Gly Trp
Ser Thr Lys Asp
Ser Thr Trp Gly
Ser Val Met Asn
Ser Val Asn Met
Ser Trp Ala Ser
Ser Trp Gly Thr
Ser Trp Ser Ala
Ser Trp Thr Gly
Thr Ala Cys Arg
Thr Ala Met Gln
Thr Ala Gln Met
Thr Ala Arg Cys
Thr Cys Ala Arg
Thr Cys Ile Asn
Thr Cys Leu Asn
Thr Cys Asn Ile
Thr Cys Asn Leu
Thr Cys Gln Val
Thr Cys Arg Ala
Thr Cys Val Gln
Thr Asp Lys Ser
Thr Asp Ser Lys
Thr Gly Ser Trp
Thr Gly Trp Ser
Thr Ile Cys Asn
Thr Ile Asn Cys
Thr Lys Asp Ser
Thr Lys Ser Asp
Thr Leu Cys Asn
Thr Leu Asn Cys
Thr Met Ala Gln
Thr Met Gln Ala
Thr Asn Cys Ile
Thr Asn Cys Leu
Thr Asn Ile Cys
Thr Asn Leu Cys
Thr Gln Ala Met
Thr Gln Cys Val
Thr Gln Met Ala
Thr Gln Thr Thr
Thr Gln Val Cys
Thr Arg Ala Cys
Thr Arg Cys Ala
Thr Ser Asp Lys
Thr Ser Gly Trp
Thr Ser Lys Asp
Thr Ser Trp Gly
Thr Thr Gln Thr
Thr Thr Thr Gln
Thr Val Cys Gln
Thr Val Gln Cys
Thr Trp Gly Ser
Thr Trp Ser Gly
Val Cys Gln Thr
Val Cys Thr Gln
Val Met Asn Ser
Val Met Ser Asn
Val Asn Met Ser
Val Asn Ser Met
Val Gln Cys Thr
Val Gln Thr Cys
Val Ser Met Asn
Val Ser Asn Met
Val Thr Cys Gln
Val Thr Gln Cys
Trp Ala Ser Ser
Trp Gly Ser Thr
Trp Gly Thr Ser
Trp Ser Ala Ser
Trp Ser Gly Thr
Trp Ser Ser Ala
Trp Ser Thr Gly
Trp Thr Gly Ser
Trp Thr Ser Gly
Tyr Gly Asn Pro
Tyr Gly Pro Asn
Tyr Asn Gly Pro
Tyr Asn Pro Gly
Tyr Pro Gly Asn
Tyr Pro Asn Gly
Thesinine 4'-O-glucoside
(3R,5S,6E)-rel-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-Heptenoic acid ethyl ester
ETHYL [R-(R*,S*)]-3,5-DIHYDROXY-7-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLINYL]-HEPT-6-ENOATE
3-Pyridinecarboxylic acid, 4-[4-fluoro-2-(phenylmethoxy)phenyl]-5-formyl-2,6-bis(1-methylethyl)-, methyl ester
(E)-N-ethyl-6,6-dimethyl-N-[[3-[(4-thiophen-3-ylthiophen-2-yl)methoxy]phenyl]methyl]hept-2-en-4-yn-1-amine
NB-598 is a potent and competitive inhibitor of squalene epoxidase (SE), and suppresses triglyceride biosynthesis through the farnesol pathway. NB-598 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N-[2,6-Bis(1-methylethyl)phenyl]-N-[4-[(4-nitrophenyl)thio]phenyl]urea
VULM 1457 is a potent inhibitor of cholesterol acyltransferase (acyl-CoA). VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM 1457 has the potential for the research of diabetes mellitus and hypercholesterolaemia[1][2].
N-benzyl-4-[3-[[(1-methylpiperidin-4-yl)amino]methyl]phenyl]benzenesulfonamide
(4-carbamimidoylphenyl) 4-[(E)-3-[(2-ethoxy-2-oxoethyl)-prop-2-enylamino]-2-methyl-3-oxoprop-1-enyl]benzoate
2-[4-[4-(Diphenylmethyl)-1-piperazinyl]but-2-ynyl]isoindole-1,3-dione
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-[3-(1-pyrrolidinyl)propyl]acetamide
N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-thiophenecarboxamide
(9R,10R)-10-hydroxy-9-methoxy-10-(4-methoxyphenyl)-2-methyl-2-(4-methylpent-3-enyl)-7,9-dihydropyrano[2,3-]quinolin-8-one
N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide
[4-(2,5-Diphenyl-7-pyrazolo[1,5-a]pyrimidinyl)-1-piperazinyl]-(3-furanyl)methanone
trans-4-[({2-[(2-oxo-3-phenyl-2H-chromen-7-yl)oxy]propanoyl}amino)methyl]cyclohexanecarboxylic acid
N-[3-(3,5-dimethyl-1-pyrazolyl)-2-hydroxypropyl]-N-(4-methylphenyl)-2-naphthalenesulfonamide
(E)-2-Cyano-3-(2-dibenzylamino-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)-N-methyl-acrylamide
3-[4-[(E,3E)-3-(1,3,3-trimethylindol-2-ylidene)prop-1-enyl]quinolin-1-ium-1-yl]propane-1-sulfonic acid
(1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-6-oxo-12-(2-pyridin-2-ylacetyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-1-[1-oxo-2-(3-pyridinyl)ethyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-6-oxo-12-(2-pyridin-2-ylacetyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
methyl (2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-6-oxo-1-(2-pyridin-3-ylacetyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylate
(1S,9R,10R,11R)-N-ethyl-10-(hydroxymethyl)-6-oxo-5-phenyl-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-N-ethyl-10-(hydroxymethyl)-6-oxo-5-phenyl-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-7-phenyl-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-[oxo(2-pyrazinyl)methyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-1-propanone
[(1S)-7-methoxy-2-methylsulfonyl-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-7-phenyl-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-[oxo(2-pyrazinyl)methyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-1-propanone
[(1R)-7-methoxy-2-methylsulfonyl-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(2,5-Dioxopyrrolidin-1-yl) 4-[3,6-bis(dimethylamino)acridin-10-ium-10-yl]butanoate
NP10679
NP10679 is a selective, pH dependent GluN2B subunit-specific N-methyl-D-aspartate (NMDA) receptor inhibitor with high oral bioavailability and good brain penetration. NP10679 inhibits GluN2B with IC50s of 23 and 142 nM at pH 6.9 and 7.6, respectively. NP10679 is a histamine H1 antagonist and a hERG channel inhibitor with IC50s of 73 and 620 nM, respectively. NP10679 is a reversible inhibitor of human liver CYP enzymes[1].